Literature DB >> 30974202

Neoline is the active ingredient of processed aconite root against murine peripheral neuropathic pain model, and its pharmacokinetics in rats.

Yohei Tanimura1, Masato Yoshida2, Kan'ichiro Ishiuchi3, Masahiro Ohsawa4, Toshiaki Makino5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Processed aconite root (PA), the root of Aconitum carmichaeli (Ranunculaceae), is a crude drug used in traditional Chinese or Japanese kampo medicine to treat pain associated with coldness. In our previous study, PA and its active ingredient, neoline, alleviated oxaliplatin-induced peripheral neuropathy in mice. AIM OF THE STUDY: The present study investigated the effects of PA on a murine peripheral neuropathy model induced by intraperitoneal injection of paclitaxel and partial ligation of the sciatic nerve (Seltzer model), and identified its active ingredients.
MATERIALS AND METHODS: PA powder (1 g/kg/day) was orally administered, and either neoline or benzoylmesaconine (10 mg/kg/day) was subcutaneously injected into the murine model. Mechanical hyperalgesia was evaluated via the von Frey filament method. PA extract was orally administered to rats; blood samples were chronologically collected, and the plasma concentrations of Aconitum alkaloids were measured. The contents of Aconitum alkaloids in commercial PA products were also measured.
RESULTS: PA extract and neoline significantly attenuated the mechanical hyperalgesia induced by either paclitaxel or partial ligation of the sciatic nerve in mice. In the plasma samples of rats treated with PA extract, higher concentrations of benzoylmesaconine and neoline were apparent among Aconitum alkaloids. The contents of benzoylmesaconine and neoline varied among PA products with different processing procedures. Subcutaneous injection of benzoylmesaconine did not attenuate the hyperalgesia induced by each paclitaxel, partial ligation of the sciatic nerve, or oxaliplatin in mice.
CONCLUSIONS: The present results indicate that PA and its active ingredient, neoline, are promising agents for the alleviation of neuropathic pain. Neoline can be used as a marker compound to determine the quality of the PA products for the treatment of neuropathic pain.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Neoline; Oxaliplatin; Paclitaxel; Partial ligation of sciatic nerve; Peripheral neuropathy; Processed aconite root

Mesh:

Substances:

Year:  2019        PMID: 30974202     DOI: 10.1016/j.jep.2019.111859

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Suppressive effects of processed aconite root on dexamethasone-induced muscle ring finger protein-1 expression and its active ingredients.

Authors:  Taishi Kondo; Tomoaki Ishida; Ke Ye; Marin Muraguchi; Yohei Tanimura; Masato Yoshida; Kan'ichiro Ishiuchi; Tomoki Abe; Takeshi Nikawa; Keisuke Hagihara; Hidetoshi Hayashi; Toshiaki Makino
Journal:  J Nat Med       Date:  2022-02-18       Impact factor: 2.343

Review 2.  Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity.

Authors:  Xiaowei Xu; Liqun Jia; Xiaoran Ma; Huayao Li; Changgang Sun
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 3.  Analgesic effects of medicinal plants and phytochemicals on chemotherapy-induced neuropathic pain through glial modulation.

Authors:  Ji Hwan Lee; Nari Kim; Sangwon Park; Sun Kwang Kim
Journal:  Pharmacol Res Perspect       Date:  2021-12

Review 4.  Goshajinkigan attenuates paclitaxel-induced neuropathic pain via cortical astrocytes.

Authors:  Kenta Takanashi; Keisuke Shibata; Keita Mizuno; Ryohei Komatsu; Schuichi Koizumi
Journal:  Pharmacol Res Perspect       Date:  2021-12

5.  In Vivo Pharmacokinetic Analysis Utilizing Non-Targeted and Targeted Mass Spectrometry and In Vitro Assay against Transient Receptor Potential Channels of Maobushisaishinto and Its Constituent Asiasari Radix.

Authors:  Takashi Matsumoto; Mikina Takiyama; Shou Sanechika; Akiko Nakayama; Katsuyuki Aoki; Katsuya Ohbuchi; Hirotaka Kushida; Hitomi Kanno; Akinori Nishi; Junko Watanabe
Journal:  Molecules       Date:  2020-09-18       Impact factor: 4.411

6.  Drug-interaction between paclitaxel and goshajinkigan extract and its constituents.

Authors:  Akiko Nakayama; Kazuaki Tsuchiya; Lingyu Xu; Takashi Matsumoto; Toshiaki Makino
Journal:  J Nat Med       Date:  2021-07-25       Impact factor: 2.343

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.